YU Miao, QIN Bing, HU Daojun, ZHANG Li. The value of serum alpha-fetoprotein, golgi protein 73, α-L-fucosidase and serum ferritin in combination in early diagnosis of primary liver cancer[J]. Journal of Clinical Medicine in Practice, 2020, 24(20): 37-39,43. DOI: 10.7619/jcmp.202020010
Citation: YU Miao, QIN Bing, HU Daojun, ZHANG Li. The value of serum alpha-fetoprotein, golgi protein 73, α-L-fucosidase and serum ferritin in combination in early diagnosis of primary liver cancer[J]. Journal of Clinical Medicine in Practice, 2020, 24(20): 37-39,43. DOI: 10.7619/jcmp.202020010

The value of serum alpha-fetoprotein, golgi protein 73, α-L-fucosidase and serum ferritin in combination in early diagnosis of primary liver cancer

More Information
  • Received Date: August 12, 2020
  • Available Online: December 21, 2020
  • Published Date: November 12, 2020
  • Objective To explore the value of serum alpha-fetoprotein(AFP), golgi protein 73(GP73), α-L-fucosidase(AFU)and serum ferritin(SF)in the early diagnosis of primary liver cancer. Methods A total of 34 patients with primary liver cancer were selected as observation group, and a total of 35 patients with benign liver disease were selected as control group. The serum levels of AFP, GP73, AFU as well as SF and the condition of combined detection were compared between the two groups. Results The serum levels of AFP, GP73, AFU and SF in the observation group showed significant difference when compared with the control group(P<0.05). The serum levels of AFP, GP73, AFU and SF in the observation group in stages of Ⅲ to Ⅳ of TNM classification showed significant difference when compared with those in stages of Ⅰ to Ⅱ of TNM classification(P<0.05). The sensitivity and accuracy of serum AFP, GP73, AFU and SF in combination were 91.18% and 82.61%, respectively, which were higher than the single detection, and the differences were statistically significant(P<0.05). Conclusion The combined detection of serum AFP, GP73, AFU and SF can significantly improve the sensitivity and accuracy, which is of great value in the diagnosis of primary liver cancer.
  • 赵睿, 王启之, 郑海伦. 原发性肝癌患者TACE前后血清GP73的变化及意义[J]. 中华全科医学, 2018, 16(10): 1623-1625.
    董阳, 戴美云, 马亚文, 等. 联合检测AFP、FER、CHI3L1和GP73在原发性肝癌诊断中的应用价值[J]. 国际消化病杂志, 2018, 38(6): 393-396

    , 406.
    陈旭东, 王倩倩, 陈巧巧. 血清GP73、AFP、AFU检测对AFP低水平原发性肝癌的诊断价值[J]. 浙江医学, 2018, 40(16): 1827-1829.
    郭鸿雁, 刘庆峰, 王蕊, 等. 血清GP73、AFP和AFP-L3联合检测诊断原发性肝癌的可行性研究[J]. 中国肿瘤临床与康复, 2018, 25(8): 908-911.
    胡恒贵, 秦淑国, 欧雁冰, 等. 透明质酸、甲胎蛋白、甲胎蛋白异质体-3和高尔基蛋白73联合检测在肝脏疾病诊断中的价值[J]. 检验医学与临床, 2018, 15(13): 1889-1891.
    黄彩云, 王晓蕊, 李世龙, 等. CT扫描联合肿瘤标志物AFP-L3、GP73诊断原发性肝癌的价值探讨[J]. 现代肿瘤医学, 2019, 27(1): 79-82.
    张立营, 赵丽艳, 赵权. GP73和AFP联合检测在原发性肝癌诊断中的价值[J]. 中国医药生物技术, 2019, 14(1): 43-45.
    黄晶, 王彦, 李国慧, 等. AFP与PIVKA-Ⅱ联合检测在原发性肝癌诊断中的应用价值研究[J]. 重庆医学, 2019, 23(A01): 358-359.
    宫英博, 李立文. 血清AFP、AFU、GP73及SF联合检测在原发性肝癌早期诊断中应用价值分析[J]. 标记免疫分析与临床, 2016, 23(6): 651-654.
    黎小花, 王群拴, 刘阿静, 等. 原发性肝癌患者血清AFP、AFU、TSGF、GP73水平变化及其CT特征分析[J]. 海南医学, 2019, 30(19): 2473-2475.
    郭致平, 殷芳. 甲胎蛋白、亮氨酸氨基肽酶及α-L-岩藻糖苷酶表达水平单独和联合检测诊断原发性肝癌的应用价值[J]. 中国综合临床, 2020, 36(2): 109-113.
    孙智珺, 夏天. CT联合血清AFP、TSGF、GP73水平检测对原发性肝癌诊断效能的影响[J]. 中国地方病防治杂志, 2018, 33(2): 229, 231.
    王钢, 陈涛, 卢峰, 等. 血清高尔基体糖蛋白73在慢性肝病诊断中的应用研究[J]. 临床输血与检验, 2018, 20(4): 428-431.
    齐杰, 高战强, 刘树昌, 等. 磁共振扩散加权成像联合血清肿瘤标志物对诊断早期原发性肝癌价值分析[J]. 临床军医杂志, 2018, 46(9): 1057-1058.
    王蓉, 蔡高涛, 钟小青, 等. 血清AFP-L3和GP-73联合检测对原发性肝癌诊断的Meta分析[J]. 现代检验医学杂志, 2019(2): 72-75, 78.
    王翠晓, 高静. 血清高尔基蛋白73、甲胎蛋白异质体3、甲胎蛋白和α-L-岩藻糖苷酶水平诊断原发性肝癌的效能分析[J]. 实用肝脏病杂志, 2019, 22(1): 113-116.
    柯昌征, 王传敏, 康健, 等. AFP、CA19-9、SF、AFU联合肝脏MRI诊断原发性肝癌的效能分析[J]. 标记免疫分析与临床, 2018, 25(5): 684-688.
    崔琦, 董延娥, 霍云龙, 等. 血清AFP、GP73、SF、DCP联合检测在原发性肝癌诊断中的应用[J]. 中国医科大学学报, 2019, 48(5): 434-436.

Catalog

    Article views (502) PDF downloads (11) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return